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Introduction
High levels of MR-proadrenomedullin (MR-proADM) have
been described in critical sepsis patients. This is directly
related to the relaxation of vascular tone and, therefore,
hypotension and the presence of organ failure in patients
with septic shock. In patients with severe pneumonia due
to influenza A, although without great hemodynamic com-
promise, the presence of respiratory failure worsens the
prognosis and significantly increases mortality.
Objective
Evaluate the usefulness of MR-proADM comparing
them to C-reactive protein (CRP) and procalcitonin
(PCT) in the prognosis of patients with influenza A
virus pneumonia.
Methods
Prospective observational multicenter study. We
included patients admitted to the ICU of five hospitals
in Spain with the diagnosis of severe sepsis during a
period of 36 months due to influenza A virus pneumo-
nia. Biomarker levels (MR-proADM, CRP, PCT) were
determined at admission. Data were compared with a
control group (CG) of patients, also with influenza virus
A pneumonia, but less severe who were not admitted to
the ICU.
Results
66 patients were included: 41 patients with severe pneu-
monia caused by influenza A virus (IAvPN) and 25
patients were included in the control group (CG).The
IAvPN group mortality was 29.26% (12/41). PCT levels
were similar in both groups: 0.3 µg/l (IQR 0.00-1.175)
in the GC and 0,27µg/l (IQR 0.155-0.700) in the
IAvPN group. The levels of CRP at admission were 9.2
mg / dl (IQR 5.6-14,3) in IAvPN and 6.37 mg / dl (IQR
2.5-10.93) in the CG (p = 0.112). The MR-proADM
levels at admission were 1.40 nmol / l (IQR 0994-2374)
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Figure 1 Initial CRP, PCT and MR-proADM levels.
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IAvPN against 0.5437 nmol / l (IQR from 0.404 to
0.891) in the CG (p = 0.001) (Figure 1).
The area under the ROC curve (AUC) for prognostic
severity (ICU admission) was 0.6769 (p < 0.0961) for
CRP levels, 0.5767 (p < 0.543) for PCT levels and
0.87058 for MR-proADM levels (p < 0.0001). The opti-
mal cutoff for severity (ICU admission) MR_proADM
levels at admission was 1.09 nmol / l, with a sensitivity
of 73.53% and a specificity of 96%.(Figure 2).
The non survivors showed greater MR-proADM levels
with a median of 1.622 nmol / l (IQR 1.35-4.420) vs
0.8606 nmol/l (IQR 0.459-1.382) in the survivors (p =
0.0014). the PCT and CRP levels showed no significant
difference in mortality groups. The AUC the ROC curve
for prognostic mortality was: MR-proADM 0.838 (p =
0.0001); PCT 0.599 (p = 0.591) CRP 0.6400 (p = 0.0072)
(Figure 3).
In the multivariate analysis (Cox proportional hazards
models) only MR-proADM levels at admission, were
statistically significant predictive factors for mortality in
the ICU and at 90 days.(Table 1)
Conclusions
Initial MR-proADM levels are effective to determine the
unfavorable outcome and the risk of ICU admission and
mortality in patients with pneumonia due to influenza A
virus.
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Figure 2 MR-proADM ROC curve for prognostic severity.
Figure 3 proADM ROC curve for prognostic mortality.
Table 1 multivariate analysis (Cox models)











2.4931 (1.269-4.895) 0.9135 0.3460 p = 0.0083
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